Problem Solver
Gonçalo Real
Areas Gonçalo Real is Knowledgeable in:
Molecular Biology, Microbiology, Protein Production using Eucaryotic and Procaryotic systems, Vivarl vector construction (lentivirus), Cell line development
Techniques Gonçalo Real Uses:
The Animal Cell Technology Unit focuses its research on three major areas:
Biopharmaceutical process development
■Recombinant proteins including monoclonal antibodies
■Viral vaccines
■Viral vectors for gene therapy
Stem cell bioprocessing and cell therapy
Development of in-vitro models for pre-clinical research
■Toxicology
■Brain research
■Cancer research
Biopharmaceutical process development
■Recombinant proteins including monoclonal antibodies
■Viral vaccines
■Viral vectors for gene therapy
Stem cell bioprocessing and cell therapy
Development of in-vitro models for pre-clinical research
■Toxicology
■Brain research
■Cancer research
Gonçalo Real's Problem Solving Skills:
- Cell line development
- Viral Vector design
- Protein Production and Purification
- Microbiology
- Molecular Biology
Gonçalo Real's Problem Solving Experience:
- The Animal Cell Technology Unit (ACTU) of iBETfor which I am Project Manager is a top research group combining knowledge and competences of scientists from a wide range of disciplines (Biochemistry, Biology and Engineering). Our know-how in terms of biopharmaceuticals spans from the initial expression vector design and cell line establishment through all stages of process development and scale-up (production, purification, stability and storage). Additionally, the recognized potential of cell- and gene-based therapies led us to develop expertise in both areas. In recent years, the ACTU has been dedicating substantial effort in the development of new in vitro models for pre-clinical research.The ACTU participates in several international projects Framework European Commission Programs and is a member of CLINIGENE, an international Network of Excellence in Gene and Cell therapy and collaborates with several pharmaceutical companies, biotech SMEs and academic institutions.